Critical Review: Bonk (BNKK) & Its Competitors

Bonk (NASDAQ:BNKK) is one of 345 public companies in the “Financial Services” industry, but how does it contrast to its peers? We will compare Bonk to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, valuation and risk.

Analyst Ratings

This is a summary of recent recommendations for Bonk and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1891	6807	11500	414	2.51

As a group, “Financial Services” companies have a potential upside of 4.09%. Given Bonk’s peers stronger consensus rating and higher possible upside, analysts clearly believe Bonk has less favorable growth aspects than its peers.

Risk and Volatility

Bonk has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Comparatively, Bonk’s peers have a beta of 2.26, indicating that their average share price is 126% more volatile than the S&P 500.

Profitability

This table compares Bonk and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-405.59%	-21.92%	-5.67%

Insider & Institutional Ownership

12.6% of Bonk shares are owned by institutional investors. Comparatively, 43.0% of shares of all “Financial Services” companies are owned by institutional investors. 51.6% of Bonk shares are owned by insiders. Comparatively, 21.8% of shares of all “Financial Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Bonk and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.32
Bonk Competitors	$24.20 billion	$1.07 billion	10.49

Bonk’s peers have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Bonk peers beat Bonk on 12 of the 13 factors compared.

About Bonk

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.